Inhibition of lung cancer growth and metastasis by DHA and its metabolite, RvD1, through miR-138-5p/FOXC1 pathway
2019 · Journal of Experimental & Clinical Cancer Research · 91 citations
https://doi.org/10.1186/s13046-019-1478-3
S
Sujin Zhou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
42
Papers
465
Citations
12
h-index
15
i10-index
Sujin Zhou is an academic researcher from Guangdong University of Technology. The author has contributed to research in topics: Cancer Research and Treatments & Phosphodiesterase function and regulation & Adipokines, Inflammation, and Metabolic Diseases. The author has an h-index of 12, co-authored 36 publications.
ORCID: 0000-0002-3233-4094Papers by this author
worksTargeted deprivation of methionine with engineered Salmonella leads to oncolysis and suppression of metastasis in broad types of animal tumor models
2023 · Cell Reports Medicine · 33 citations
https://doi.org/10.1016/j.xcrm.2023.101070
Adiponectin suppresses tumor growth of nasopharyngeal carcinoma through activating AMPK signaling pathway
2022 · Journal of Translational Medicine · 23 citations
https://doi.org/10.1186/s12967-022-03283-0
Pharmacological targeting of type phosphodiesterase 4 inhibits the development of acute myeloid leukemia by impairing mitochondrial function through the Wnt/β-catenin pathway
2022 · Biomedicine & Pharmacotherapy · 7 citations
https://doi.org/10.1016/j.biopha.2022.114027
The phosphodiesterase-4 inhibitor Zl-n-91 suppresses glioblastoma growth via EGR1/PTEN/AKT pathway
2024 · European Journal of Pharmacology · 4 citations
https://doi.org/10.1016/j.ejphar.2024.177230
Cyclic adenosine monophosphate potentiates immune checkpoint blockade therapy in acute myeloid leukemia
2023 · Clinical and Translational Medicine · 0 citations
https://doi.org/10.1002/ctm2.1489
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat